Green Vision Biotechnology Corp.  (GVBT)
Other Ticker:  


Green Vision Biotechnology Corp.

GVBT's Financial Statements and Analysis

Green Vision Biotechnology Corp. reported break-eaven for the II. Quarter compare to net loss per share of $-0.08 recorded in the same quarter a year ago an improvement compare to $0.00 realized in previous quarter.

II. Quarter
Earnings Per Share Revenues
$ 0 $  0 Mill
$+0.08     Unch.    

Green Vision Biotechnology's Revenue fell by 0 % in II. Quarter (Jun 30 2022) year on year, to $0 million and declined by sequentially.

Green Vision Biotechnology is Expected to report next financial results on March 30, 2023.

More on GVBT's Income Statement

Green Vision Biotechnology's in II. Quarter recorded net loss of $-0.087 million, an improvement compare to net loss of $-0.126 million in II. Quarter a year ago.

Sequentially net loss narrowed from net loss of $-1.155 million realized in previous quarter.

More on GVBT's Growth

In II. Quarter company's net cash and cash equivalents decreased by $0 million

Green Vision Biotechnology Corp. does not pay out common stock dividend.

In trailing twelve-month period Green Vision Biotechnology Corp. payed $ -3,234,555.56 cash per share, on a free-cash flow basis .